Gene therapy progress and prospects: Parkinson's disease.
Burton
E A
EA
Department of Clinical Neurology, University of Oxford, Radcliffe Infirmary, Oxford, UK.
Glorioso
J C
JC
Fink
D J
DJ
D000818:Animals; D017209:Apoptosis / Q000235:genetics; D001921:Brain / Q000378:metabolism / Q000473:pathology; D004298:Dopamine / Q000096:biosynthesis; D005544:Forecasting; D015316:Genetic Therapy / Q000379:methods / Q000639:trends*; D005822:Genetic Vectors / Q000008:administration & dosage / Q000235:genetics; D051100:Glial Cell Line-Derived Neurotrophic Factor; D006801:Humans; D023421:Models, Animal; D009414:Nerve Growth Factors / Q000235:genetics; D010300:Parkinson Disease / Q000235:genetics / Q000517:prevention & control / Q000628:therapy*; D013234:Stem Cells / Q000378:metabolism; D014161:Transduction, Genetic / Q000379:methods
C495039:GDNF protein, human; D051100:Glial Cell Line-Derived Neurotrophic Factor; D009414:Nerve Growth Factors; D004298:Dopamine